BioLizard announces the appointment of André van de Sande as Chairman of the Board
Ghent (Belgium), January 30, 2024 – BioLizard is pleased to announce the appointment of André van de Sande as the new Chair of our Board of Directors.
As a Senior Executive with 30 years of life sciences experience and a track record in both mature and emerging markets across the regions of Western and Central Europe, Asia Pacific, Middle East and Africa, André van de Sande brings highly valuable, proven expertise to BioLizard. Having already served as a Strategic Advisor to BioLizard starting in 2020, and thereafter as Board Member & Independent Director since spring 2023, we are thrilled to now welcome him as Chairman of the Board.
Liesbeth Ceelen, PhD, CEO of BioLizard, elaborated: “André’s impressive history of accomplishments in pharma, biotech, and consulting, together with his demonstrated success in company expansion, clearly establishes him as the ideal candidate for the Chairman of the Board role. I am greatly looking forward to the chance to continue working alongside him. Having recently announced our Swiss subsidiary, alongside our presence in the US, the Netherlands, and Belgium, André’s appointment to Chair of the BioLizard Board of Directors comes at an ideal time to support our ongoing international expansion, and our service commitment to partners and clients across borders.”
André van de Sande said: “In my capacity as external advisor, I got to know BioLizard in the past three years as a very dynamic and rapidly growing consultancy company in the bioinformatics, data analytics, and data governance space. I am impressed by the quality of the team and by what has already been achieved. I look forward to contributing my knowledge and experience as Chairman to help bring BioLizard to the next phase of their development.”
Mr. van de Sande has successfully led organisations ranging from 40 to 1400 employees as CEO, Managing Director, and Regional Vice President. He has extensive change management experience and broad non-executive and advisory board experience. In addition, he holds an MBA degree from Tilburg University and an MSc in Management from Purdue University, USA, and he has followed the supervisory board member program of Nyenrode University, The Netherlands.
BioLizard is a leading multi-national bioinformatics, data analytics and data management service and consulting company heading digital transformation in the life sciences industry. Headquartered in Ghent, Belgium, BioLizard is the trusted go-to partner for data strategy and execution with companies across the range from drug discovery to clinical research and diagnostics. BioLizard accommodates a uniquely qualified team of 50+ experts, ”The Lizards“, who bring together their expertise and abilities, covering data management, software engineering, bioinformatics, advanced data analytics, and AI. Their joint backgrounds in biology and computer sciences enables them to apply specialist understanding to each client’s data environment, to provide insights and tools that are aligned with the client’s goals and maximize R&D return on investment. For further information, please visit https://lizard.bio/ and follow us on LinkedIn.